Bill Text: MN HF284 | 2019-2020 | 91st Legislature | Engrossed
Bill Title: Insulin products sold in Minnesota cost review authorized by commissioner of health, excessive cost determined, maximum level of reimbursement established for insulin products if necessary, and money appropriated.
Spectrum: Partisan Bill (Democrat 15-0)
Status: (Introduced - Dead) 2019-04-01 - Author added Bierman [HF284 Detail]
Download: Minnesota-2019-HF284-Engrossed.pdf